Overview

Coronaviruses are a family of viruses that can cause illnesses such as the common cold, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). In 2019, a new coronavirus was identified as the cause of a disease outbreak that originated in China.

The virus is known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease it causes is called coronavirus disease 2019 (COVID-19). In March 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a pandemic.

Public health groups, including the U.S. Centers for Disease Control and Prevention (CDC) and WHO, are monitoring the COVID-19 pandemic and posting updates on their websites. These groups have also issued recommendations for preventing and treating the virus that causes COVID-19.

Symptoms

Signs and symptoms of coronavirus disease 2019 (COVID-19) may appear 2 to 14 days after exposure. This time after exposure and before having symptoms is called the incubation period. You can still spread COVID-19 before you have symptoms (presymptomatic transmission). Common signs and symptoms can include:

  • Fever
  • Cough
  • Tiredness

Early symptoms of COVID-19 may include a loss of taste or smell.

Other symptoms can include:

  • Shortness of breath or difficulty breathing
  • Muscle aches
  • Chills
  • Sore throat
  • Runny nose
  • Headache
  • Chest pain
  • Pink eye (conjunctivitis)
  • Nausea
  • Vomiting
  • Diarrhea
  • Rash

This list isn't complete. Children have similar symptoms to adults and generally have mild illness.

The severity of COVID-19 symptoms can range from very mild to severe. Some people may have only a few symptoms. Some people may have no symptoms at all, but can still spread it (asymptomatic transmission). Some people may experience worsened symptoms, such as worsened shortness of breath and pneumonia, about a week after symptoms start.

Some people experience COVID-19 symptoms for more than four weeks after they're diagnosed. These health issues are sometimes called post-COVID-19 conditions. Some children experience multisystem inflammatory syndrome, a syndrome that can affect some organs and tissues, several weeks after having COVID-19. Rarely, some adults experience the syndrome too.

People who are older have a higher risk of serious illness from COVID-19, and the risk increases with age. People who have existing medical conditions also may have a higher risk of serious illness. Certain medical conditions that may increase the risk of serious illness from COVID-19 include:

  • Serious heart diseases, such as heart failure, coronary artery disease or cardiomyopathy
  • Cancer
  • Chronic obstructive pulmonary disease (COPD)
  • Type 1 or type 2 diabetes
  • Overweight, obesity or severe obesity
  • High blood pressure
  • Smoking
  • Chronic kidney disease
  • Sickle cell disease or thalassemia
  • Weakened immune system from solid organ transplants or bone marrow transplants
  • Pregnancy
  • Asthma
  • Chronic lung diseases such as cystic fibrosis or pulmonary hypertension
  • Liver disease
  • Dementia
  • Down syndrome
  • Weakened immune system from bone marrow transplant, HIV or some medications
  • Brain and nervous system conditions, such as strokes
  • Substance use disorders

This list is not complete. Other medical conditions may increase your risk of serious illness from COVID-19.

COVID-19 self-checker

Assess your symptoms on CDC’s coronavirus self-checker tool and find out if you’re a candidate for a COVID-19 test.

When to see a doctor

If you have COVID-19 signs or symptoms or you've been in contact with someone diagnosed with COVID-19, contact your health care provider right away for medical advice. Your health care provider will likely recommend that you get tested for COVID-19. If you have emergency COVID-19 symptoms, such as trouble breathing, seek care immediately. If you need to go to a hospital, call ahead so that health care providers can take steps to ensure that others aren't exposed.

If you have emergency COVID-19 signs and symptoms, seek care immediately. Emergency signs and symptoms can include:

  • Trouble breathing
  • Persistent chest pain or pressure
  • Inability to stay awake
  • New confusion
  • Pale, gray or blue-colored skin, lips or nail beds — depending on skin tone

This list isn't complete. Let your health care provider know if you are an older adult or have chronic medical conditions, such as heart disease or lung disease, as you may have a greater risk of becoming seriously ill with COVID-19.

From Mayo Clinic to your inbox

Sign up for free, and stay up to date on research advancements, health tips and current health topics, like COVID-19, plus expertise on managing health.

To provide you with the most relevant and helpful information, and understand which information is beneficial, we may combine your email and website usage information with other information we have about you. If you are a Mayo Clinic patient, this could include protected health information. If we combine this information with your protected health information, we will treat all of that information as protected health information and will only use or disclose that information as set forth in our notice of privacy practices. You may opt-out of email communications at any time by clicking on the unsubscribe link in the e-mail.

Causes

Infection with severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2, causes coronavirus disease 2019 (COVID-19).

The virus that causes COVID-19 spreads easily among people. Data has shown that the COVID-19 virus spreads mainly from person to person among those in close contact (within about 6 feet, or 2 meters). The virus spreads by respiratory droplets released when someone with the virus coughs, sneezes, breathes, sings or talks. These droplets can be inhaled or land in the mouth, nose or eyes of a person nearby.

Sometimes the COVID-19 virus can spread when a person is exposed to very small droplets or aerosols that stay in the air for several minutes or hours — called airborne transmission.

The virus can also spread if you touch a surface with the virus on it and then touch your mouth, nose or eyes. But the risk is low.

The COVID-19 virus can spread from someone who is infected but has no symptoms. This is called asymptomatic transmission. The COVID-19 virus can also spread from someone who is infected but hasn't developed symptoms yet. This is called presymptomatic transmission.

It's possible to get COVID-19 twice or more, but this is uncommon.

When a virus has one or more new mutations it’s called a variant of the original virus. The omicron (B.1.1.529) variant spreads more easily than the original virus that causes COVID-19 and the delta variant. However, omicron appears to cause less severe disease. People who are fully vaccinated can get breakthrough infections and spread the virus to others. But the COVID-19 vaccines are effective at preventing severe illness. This variant also reduces the effectiveness of some monoclonal antibody treatments. Omicron has a few major offshoots (sublineages), including BA.5 and BA.2.12.1. BA.5 made up about 54% of COVID-19 infections that had genetic sequencing in the U.S. during the last week in June, according to the CDC.

In April, the CDC downgraded the delta variant from a variant of concern to a variant being monitored. This means that the delta variant isn’t currently considered a major public health threat in the U.S.

Risk factors

Risk factors for COVID-19 appear to include:

  • Close contact (within 6 feet, or 2 meters) with someone who has COVID-19
  • Being coughed or sneezed on by an infected person

Complications

Although most people with COVID-19 have mild to moderate symptoms, the disease can cause severe medical complications and lead to death in some people. Older adults or people with existing medical conditions are at greater risk of becoming seriously ill with COVID-19.

Complications can include:

  • Pneumonia and trouble breathing
  • Organ failure in several organs
  • Heart problems
  • A severe lung condition that causes a low amount of oxygen to go through your bloodstream to your organs (acute respiratory distress syndrome)
  • Blood clots
  • Acute kidney injury
  • Additional viral and bacterial infections

Prevention

The U.S. Food and Drug Administration (FDA) has given emergency use authorization to some COVID-19 vaccines in the United States. The FDA has approved the Pfizer-BioNTech COVID-19 vaccine, now called Comirnaty, to prevent COVID-19 in people age 16 and older. The FDA has given emergency use authorization to Pfizer-BioNTech COVID-19 vaccines for ages 6 months through 15. The FDA has approved the Moderna vaccine, now called Spikevax, to prevent COVID-19 in people age 18 and older. The FDA has also authorized the Moderna COVID-19 vaccine in children ages 6 months through 17 years old. The FDA has also authorized the Novavax COVID-19, adjuvanted vaccine to prevent COVID-19 in people age 18 and older.

Due to the risk of a potentially life-threatening blood-clotting problem, the FDA is restricting use of the Janssen/Johnson & Johnson vaccine to certain people age 18 and older. Examples include people who had a severe allergic reaction after getting an mRNA COVID-19 vaccine and people who can't get an mRNA COVID-19 vaccine due to limited access or personal or religious concerns. If you get this vaccine, be sure to understand the risks and symptoms of the blood-clotting problem.

A vaccine can prevent you from getting the COVID-19 virus or prevent you from becoming seriously ill if you get the COVID-19 virus. In addition, COVID-19 vaccination might offer better protection than getting sick with COVID-19. A recent study showed that unvaccinated people who already had COVID-19 are more than twice as likely as fully vaccinated people to get reinfected with COVID-19.

After getting vaccinated, you can more safely return to many activities you may not have been able to do because of the pandemic. However, if you are in an area with a high number of people with COVID-19 in the hospital and new COVID-19 cases, the CDC recommends wearing a mask indoors in public. You're considered fully vaccinated two weeks after you get a second dose of an mRNA COVID-19 vaccine or two weeks after you get a single dose of the Janssen/Johnson & Johnson COVID-19 vaccine. You are considered up to date with your vaccines if you have gotten all recommended COVID-19 vaccines, including booster doses, when you become eligible.

An additional primary dose of a COVID-19 vaccine is recommended for people who are vaccinated and might not have had a strong enough immune response.

In contrast, a booster dose is recommended for people who are vaccinated and whose immune response weakened over time. Research suggests that getting a booster dose can decrease your risk of infection and severe illness with COVID-19.

People who have a moderately or severely weakened immune system should get an additional primary shot and a booster shot.

The CDC recommends additional doses and booster doses of COVID-19 vaccines in specific instances:

  • Additional dose. The CDC recommends a third dose of an mRNA COVID-19 vaccine for some people with weakened immune systems, such as those who have had an organ transplant. People with weakened immune systems might not develop enough immunity after vaccination with two doses of an mRNA COVID-19 vaccine. An additional dose might improve their protection against COVID-19. This recommendation is for people age 5 and older.

    The third dose should be given at least 28 days after a second dose of an mRNA COVID-19 vaccine. The additional dose should be the same brand as the other two mRNA COVID-19 vaccine doses you were given. If the brand given isn't known, either brand of mRNA COVID-19 vaccine can be given as a third dose.

  • Booster dose. These recommendations differ by age, what vaccines you have been given and the state of your immune system.

    Kids ages 5 through 17 should get a Pfizer-BioNTech COVID-19 booster shot if they been given both doses of the Pfizer-BioNTech COVID-19 vaccine and it’s been at least five months. Currently, booster doses aren’t recommended for any children or teens who get the Moderna COVID-19 vaccine for their first two doses.

    If you are age 18 or older, have been given both doses of the Moderna COVID-19 vaccine and it’s been at least 5 months, you should get a single booster dose. The Pfizer-BioNTech or Moderna COVID-19 vaccine boosters are preferred in most situations.

    If you are age 18 or older, have been given one dose of the Janssen/Johnson & Johnson COVID-19 vaccine and it’s been at least 2 months, you should get a single booster dose. The Pfizer-BioNTech or Moderna COVID-19 vaccine boosters are preferred in most situations.

    Pregnant women may also receive a COVID-19 booster shot.

    Kids ages 5 through 17 who have a weakened immune system should get a Pfizer-BioNTech COVID-19 vaccine booster shot if they have been given both doses of the Pfizer-BioNTech COVID-19 vaccine and it’s been at least three months since the additional primary shot.

    If you are age 18 or older, have a weakened immune system and had two doses of an mRNA COVID-19 vaccine and an additional primary shot, and it’s been at least two months since the additional shot, get a single booster dose. An mRNA COVID-19 vaccine is preferred.

    If you are age 18 and older, have a weakened immune system and had one dose of the Janssen/Johnson & Johnson COVID-19 vaccine and an additional primary shot of an mRNA COVID-19 vaccine, and it’s been at least two months since the additional shot, get a single booster dose. An mRNA COVID-19 vaccine is preferred.

  • Second booster dose. A second booster dose of an mRNA COVID-19 vaccine is recommended for certain people who have a weakened immune system and people age 50 or older. This second booster dose can be given to those eligible four months after a first booster dose of any authorized or approved COVID-19 vaccine.

    A second booster dose of an mRNA COVID-19 is also recommended for people who got two doses of the Janssen/Johnson & Johnson COVID-19 vaccine at least four months ago.

    You might consider delaying getting a second booster dose if you had COVID-19 in the past three months or if getting a second booster dose now would make you not want to get another booster in the future.

    Kids age 12 and older who have a weakened immune system, got both doses of the Pfizer-BioNTech COVID-19 vaccine and got a single booster dose of the Pfizer-BioNTech COVID-19 vaccine at least four months ago can also get a second booster dose of the Pfizer-BioNTech COVID-19 vaccine.

The FDA has also authorized the monoclonal antibodies tixagevimab and cilgavimab (Evusheld) to prevent COVID-19 in some people with weakened immune systems or a history of severe reactions to a COVID-19 vaccine.

There are many steps you can take to reduce your risk of infection from the COVID-19 virus and reduce the risk of spreading it to others. WHO and CDC recommend following these precautions:

  • Get vaccinated. COVID-19 vaccines reduce the risk of getting and spreading COVID-19.
  • Avoid close contact (within about 6 feet, or 2 meters) with anyone who is sick or has symptoms.
  • Keep distance between yourself and others (within about 6 feet, or 2 meters) when you're in indoor public spaces if you're not fully vaccinated. This is especially important if you have a higher risk of serious illness. Keep in mind some people may have COVID-19 and spread it to others, even if they don't have symptoms or don't know they have COVID-19.
  • Avoid crowds and indoor places that have poor air flow (ventilation).
  • Wash your hands often with soap and water for at least 20 seconds, or use an alcohol-based hand sanitizer that contains at least 60% alcohol.
  • Wear a face mask in indoor public spaces if you're in an area with a high number of people with COVID-19 in the hospital and new COVID-19 cases, whether or not you're vaccinated. The CDC recommends wearing the most protective mask possible that you'll wear regularly, fits well and is comfortable.
  • Cover your mouth and nose with your elbow or a tissue when you cough or sneeze. Throw away the used tissue. Wash your hands right away.
  • Avoid touching your eyes, nose and mouth.
  • Avoid sharing dishes, glasses, towels, bedding and other household items if you're sick.
  • Clean and disinfect high-touch surfaces, such as doorknobs, light switches, electronics and counters, regularly.
  • Stay home from work, school and public areas and stay home in isolation if you're sick, unless you're going to get medical care. Avoid public transportation, taxis and ride-hailing services if you're sick.

If you have a chronic medical condition and may have a higher risk of serious illness, check with your doctor about other ways to protect yourself.

Travel

If you're planning to travel, first check the CDC and WHO websites for updates and advice. The CDC recommends that you wear a mask on planes, buses, trains and other public transportation traveling to, within or out of the U.S., as well as in places such as airports and train stations. Use appropriate hand hygiene when in public. You may also want to talk with your health care provider if you have health conditions that make you more susceptible to respiratory infections and complications.

July 23, 2022
  1. Coronavirus disease 2019 (COVID-2019). Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/index.html. Accessed May 10, 2022.
  2. Coronavirus disease (COVID-19) outbreak. World Health Organization. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed Oct. 22, 2021.
  3. AskMayoExpert. COVID-19: Inpatient management (adult). Mayo Clinic; 2021.
  4. AskMayoExpert. Upper respiratory tract infection. Mayo Clinic; 2020.
  5. Tosh PK (expert opinion). Mayo Clinic. March 16, 2020.
  6. What you should know about coronavirus disease 2019 (COVID-19). American Academy of Otolaryngology – Head and Neck Surgery. https://www.enthealth.org/be_ent_smart/what-you-should-know-about-coronavirus-disease-2019-covid-19/. Accessed Nov. 9, 2021.
  7. McIntosh K. Coronavirus disease 2019 (COVID-19): Epidemiology, virology, clinical features, diagnosis, and prevention. https://www.uptodate.com/contents/search. Accessed Nov. 9, 2021.
  8. Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health. https://covid19treatmentguidelines.nih.gov/introduction/. Accessed Feb. 18, 2022.
  9. Emergency use authorization. U.S. Food & Drug Administration. https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization. Accessed Feb. 18, 2022.
  10. Coronavirus (COVID-19) update: FDA authorizes first standalone at-home sample collection kit that can be used with certain authorized tests. U.S. Food & Drug Administration. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-standalone-home-sample-collection-kit-can-be-used. Accessed May 20, 2020.
  11. Coronavirus (COVID-19) update: FDA authorizes first diagnostic test using at-home collection of saliva specimens. U.S. Food & Drug Administration. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-diagnostic-test-using-home-collection-saliva. Accessed May 20, 2020.
  12. Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html. Accessed June 29, 2020.
  13. Speth MM, et al. Olfactory dysfunction and sinonasal symptomatology in COVID-19: Prevalence, severity, timing, and associated characteristics. Otolaryngology-Head and Neck Surgery. 2020; doi:10.1177/0194599820929185.
  14. Marshall WF (expert opinion). Mayo Clinic. Nov. 23, 2020.
  15. Vaccines and related biological products advisory committee meeting. U.S. Food and Drug Administration. https://www.fda.gov/media/144245/download. Accessed Dec. 9, 2020.
  16. AskMayoExpert. COVID-19: Vaccination. Mayo Clinic; 2021.
  17. Science Brief: SARS-CoV-2 and surface (fomite) transmission for indoor community environments. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/more/science-and-research/surface-transmission.html. Accessed April 13, 2021.
  18. Interim public health recommendations for fully vaccinated people. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/fully-vaccinated-guidance.html. Accessed Dec. 15, 2021.
  19. Coronavirus (COVID-19) update: FDA authorizes additional vaccine dose for certain immunocompromised individuals. U.S. Food and Drug Administration. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-vaccine-dose-certain-immunocompromised. Accessed Aug. 13, 2021.
  20. Talking with patients who are immunocompromised. Centers for Disease Control and Prevention. https://www.cdc.gov/vaccines/covid-19/clinical-considerations/immunocompromised-patients.html. Accessed Aug. 16, 2021.
  21. COVID-19 vaccines for moderately to severely immunocompromised people. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immuno.html. Accessed Aug. 16, 2021.
  22. Joint CDC and FDA statements on vaccine booster. U.S. Food and Drug Administration. https://www.fda.gov/news-events/press-announcements/joint-cdc-and-fda-statement-vaccine-boosters. Accessed Aug. 16, 2021.
  23. Comirnaty and Pfizer-BioNTech COVID-19 vaccine frequently asked questions. U.S. Food and Drug Administration. https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/comirnaty-and-pfizer-biontech-covid-19-vaccine-frequently-asked-questions. Accessed Aug. 23, 2021.
  24. CDC statement on ACIP booster recommendations. Centers for Disease Control and Prevention. https://www.cdc.gov/media/releases/2021/p0924-booster-recommendations-.html. Accessed Sept. 24, 2021.
  25. Frequently asked questions about COVID-19 vaccination. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/faq.html. Accessed Oct. 1, 2021.
  26. CDC expands eligibility for COVID-19 booster shots. Centers for Disease Control and Prevention. https://www.cdc.gov/media/releases/2021/p1021-covid-booster.html. Accessed Oct. 22, 2021.
  27. Pfizer-BioNTech COVID-19 frequently asked questions. U.S. Food and Drug Administration. https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/pfizer-biontech-covid-19-vaccine-frequently-asked-questions. Accessed Nov. 3, 2021.
  28. FDA authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in children 5 through 11 years of age. U.S. Food and Drug Administration. https://www.fda.gov/news-events/press-announcements/fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use-children-5-through-11-years-age. Accessed Nov. 3, 2021.
  29. Coronavirus (COVID-19) update: FDA expands eligibility for COVID-19 vaccine boosters. U.S. Food and Drug Administration. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-expands-eligibility-covid-19-vaccine-boosters. Accessed Nov. 19, 2021.
  30. COVID-19 vaccine booster shots. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/booster-shot.html. Accessed Jan. 6, 2022.
  31. Coronavirus (COVID-19) update: FDA expands eligibility for Pfizer-BioNTech COVID-19 booster dose to 16- and 17-year-olds. U.S. Food and Drug Administration. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-expands-eligibility-pfizer-biontech-covid-19-booster-dose-16-and-17. Accessed Dec. 9, 2021.
  32. Coronavirus (COVID-19) update: FDA authorizes new long-acting monoclonal antibodies for pre-exposure prevention of COVID-19 in certain individuals. U.S. Food and Drug Administration. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-new-long-acting-monoclonal-antibodies-pre-exposure. Accessed Dec. 9, 2021.
  33. CDC endorses ACIP’s updated COVID-19 vaccine recommendations. Centers for Disease Control and Prevention. https://www.cdc.gov/media/releases/2021/s1216-covid-19-vaccines.html. Accessed Dec. 17, 2021.
  34. Stay up to date with your vaccines. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html. Accessed June 29, 2022.
  35. Types of masks and respirators. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/types-of-masks.html. Accessed Jan. 17, 2021.
  36. Spikevax and Moderna COVID-19 vaccine. U.S. Food and Drug Administration. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/spikevax-and-moderna-covid-19-vaccine. Accessed Jan. 31, 2022.
  37. Coronavirus (COVID-19) update: FDA authorizes new monoclonal antibody for treatment of COVID-19 that retains activity against omicron variant. U.S. Food & Drug Administration. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-new-monoclonal-antibody-treatment-covid-19-retains. Accessed Feb. 17, 2022.
  38. Use and care of masks. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/about-face-coverings.html. Accessed Feb. 28, 2022.
  39. COVID-19 community levels. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/science/community-levels.html. Accessed Feb. 28, 2022.
  40. Interim clinical considerations for use of COVID-19 vaccines currently approved or authorized in the United States. Centers for Disease Control and Prevention. https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html#CoV-19-vaccination. Accessed March 30, 2022.
  41. Coronavirus (COVID-19) update: FDA authorizes second booster dose of two COVID-19 vaccines for older and immunocompromised individuals. U.S. Food and Drug Administration. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-second-booster-dose-two-covid-19-vaccines-older-and. Accessed March 30, 2022.
  42. Coronavirus (COVID-19) update: FDA limits use of Janssen COVID-19 vaccine to certain individuals. U.S. Food and Drug Administration. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-limits-use-janssen-covid-19-vaccine-certain-individuals. Accessed May 9, 2022.
  43. Novavax COVID-19, adjuvanted vaccine: Overview and safety. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/novavax.html. Accessed July 20, 2022.

Related

News from Mayo Clinic

Products & Services